Regulators on Wednesday said materials with harmful chemicals known as "PFAS" are no longer being sold to package microwave popcorn or other greasy foods in the United States.
Feb 29, 2024
0
0
Human safety trials of a novel antibiotic treatment for Lyme disease developed by Northeastern professor Kim Lewis are scheduled to start this spring in Australia, with results anticipated by fall.
Feb 29, 2024
0
1
Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, is one of the first centers nationwide to offer a newly approved cell-based immunotherapy that targets melanoma.
Feb 24, 2024
0
1
Smartwatches and rings that claim to measure blood sugar levels for medical purposes without piercing the skin could be dangerous and should be avoided, the U.S. Food and Drug Administration warned Wednesday.
Feb 22, 2024
0
1
Raw milk cheese tainted with E. coli bacteria has sickened 10 people in four states, hospitalizing four, federal regulators warn.
Feb 19, 2024
0
0
Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins ...
Feb 16, 2024
0
0
Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation.
Feb 15, 2024
0
0
In a new study of nasal decongestant purchasing patterns, researchers at the University of Pittsburgh School of Medicine found that phenylephrine remained the most popular choice year after year, despite decades of concerns ...
Feb 8, 2024
0
0
On Friday, a U.S. Food and Drug Administration advisory panel addressed the ongoing issue of less accurate readings from pulse oximeters when used by individuals with darker skin.
Feb 6, 2024
0
0
The U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Canget BioTekpharma LLC for FL118, a drug candidate developed at Roswell Park Comprehensive Cancer Center, as a possible treatment for pancreatic ...
Feb 5, 2024
0
0
